Regis Technologies
Burrous Martin has a diverse work experience spanning multiple industries. Burrous started their career at Quaker Oats in 1987, where they held multiple managerial roles, including Director of Finance for U.S. Gatorade. Burrous also worked at PepsiCo as a Director of Finance for U.S. Gatorade from 2002 to 2004. Martin then transitioned to RR Donnelley, where they served as the VP of Corporate Planning & Investment Analysis from 2002 to 2004. Burrous later joined Starshak Welnhofer as a Senior Financial Consultant, providing advice to corporations, governments, and non-profit organizations. Burrous currently works as the COO/CFO at Regis Technologies, a company specializing in synthesis and separations services for pharmaceutical and biotechnology companies.
Burrous Martin earned a Bachelor of Arts degree in Public Policy from Hamilton College, where they studied from 1980 to 1984. Burrous then proceeded to pursue a Master of Business Administration (MBA) with a specialization in Finance at The University of Chicago Booth School of Business, where they attended from 1986 to 1998.
Regis Technologies
Regis Technologies, Inc. partners with pharmaceutical and biotechnology companies to help advance drug candidates to market. Our services streamline and support your discovery, lead molecule development and drug commercialization – from process development and analytical development, to stability services and cGMP API manufacturing. Our facilities are routinely inspected by the FDA and other global regulatory authorities. With our extensive organic chemistry & separations expertise, Regis also manufactures an innovative line of proprietary chromatography products sold throughout the world. Regis is privately owned and operated and has been in business in the Chicagoland area since 1956.